BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28346493)

  • 1. Aberrant neuronal activity-induced signaling and gene expression in a mouse model of RASopathy.
    Altmüller F; Pothula S; Annamneedi A; Nakhaei-Rad S; Montenegro-Venegas C; Pina-Fernández E; Marini C; Santos M; Schanze D; Montag D; Ahmadian MR; Stork O; Zenker M; Fejtova A
    PLoS Genet; 2017 Mar; 13(3):e1006684. PubMed ID: 28346493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of mutations and genotype-phenotype analysis in Noonan syndrome patients with RIT1 mutations.
    Yaoita M; Niihori T; Mizuno S; Okamoto N; Hayashi S; Watanabe A; Yokozawa M; Suzumura H; Nakahara A; Nakano Y; Hokosaki T; Ohmori A; Sawada H; Migita O; Mima A; Lapunzina P; Santos-Simarro F; García-Miñaúr S; Ogata T; Kawame H; Kurosawa K; Ohashi H; Inoue S; Matsubara Y; Kure S; Aoki Y
    Hum Genet; 2016 Feb; 135(2):209-22. PubMed ID: 26714497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional hallmarks of Noonan syndrome and Noonan-like syndrome with loose anagen hair.
    Ferrero GB; Picco G; Baldassarre G; Flex E; Isella C; Cantarella D; Corà D; Chiesa N; Crescenzio N; Timeus F; Merla G; Mazzanti L; Zampino G; Rossi C; Silengo M; Tartaglia M; Medico E
    Hum Mutat; 2012 Apr; 33(4):703-9. PubMed ID: 22253195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [
    Xu HY; Yuan YY; Dai P
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Sep; 33(9):830-834. PubMed ID: 31446698
    [No Abstract]   [Full Text] [Related]  

  • 5. SHP2 sails from physiology to pathology.
    Tajan M; de Rocca Serra A; Valet P; Edouard T; Yart A
    Eur J Med Genet; 2015 Oct; 58(10):509-25. PubMed ID: 26341048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTPN11 and KRAS gene analysis in patients with Noonan and Noonan-like syndromes.
    Brasil AS; Pereira AC; Wanderley LT; Kim CA; Malaquias AC; Jorge AA; Krieger JE; Bertola DR
    Genet Test Mol Biomarkers; 2010 Jun; 14(3):425-32. PubMed ID: 20578946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature.
    De Rocca Serra-Nédélec A; Edouard T; Tréguer K; Tajan M; Araki T; Dance M; Mus M; Montagner A; Tauber M; Salles JP; Valet P; Neel BG; Raynal P; Yart A
    Proc Natl Acad Sci U S A; 2012 Mar; 109(11):4257-62. PubMed ID: 22371576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism and treatment for learning and memory deficits in mouse models of Noonan syndrome.
    Lee YS; Ehninger D; Zhou M; Oh JY; Kang M; Kwak C; Ryu HH; Butz D; Araki T; Cai Y; Balaji J; Sano Y; Nam CI; Kim HK; Kaang BK; Burger C; Neel BG; Silva AJ
    Nat Neurosci; 2014 Dec; 17(12):1736-43. PubMed ID: 25383899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noonan syndrome-associated SHP2 mutation differentially modulates the expression of postsynaptic receptors according to developmental maturation.
    Oh JY; Rhee S; Silva AJ; Lee YS; Kim HK
    Neurosci Lett; 2017 May; 649():41-47. PubMed ID: 28366775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arnold-Chiari malformation in Noonan syndrome and other syndromes of the RAS/MAPK pathway].
    Ejarque I; Millán-Salvador JM; Oltra S; Pesudo-Martínez JV; Beneyto M; Pérez-Aytés A
    Rev Neurol; 2015 May; 60(9):408-12. PubMed ID: 25912702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway.
    Tidyman WE; Rauen KA
    Expert Rev Mol Med; 2008 Dec; 10():e37. PubMed ID: 19063751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile xanthogranuloma in Noonan syndrome.
    Ali MM; Gilliam AE; Ruben BS; Tidyman WE; Rauen KA
    Am J Med Genet A; 2021 Oct; 185(10):3048-3052. PubMed ID: 34032360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular disease in Noonan syndrome.
    Pierpont ME; Digilio MC
    Curr Opin Pediatr; 2018 Oct; 30(5):601-608. PubMed ID: 30024444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gain-of-function mutations in the gene encoding the tyrosine phosphatase SHP2 induce hydrocephalus in a catalytically dependent manner.
    Zheng H; Yu WM; Waclaw RR; Kontaridis MI; Neel BG; Qu CK
    Sci Signal; 2018 Mar; 11(522):. PubMed ID: 29559584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excitatory neuron-specific SHP2-ERK signaling network regulates synaptic plasticity and memory.
    Ryu HH; Kim T; Kim JW; Kang M; Park P; Kim YG; Kim H; Ha J; Choi JE; Lee J; Lim CS; Kim CH; Kim SJ; Silva AJ; Kaang BK; Lee YS
    Sci Signal; 2019 Mar; 12(571):. PubMed ID: 30837304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noonan syndrome-associated SHP-2/Ptpn11 mutants enhance SIRPalpha and PZR tyrosyl phosphorylation and promote adhesion-mediated ERK activation.
    Eminaga S; Bennett AM
    J Biol Chem; 2008 May; 283(22):15328-38. PubMed ID: 18378677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Noonan Syndrome-linked Raf1L613V mutation drives increased glial number in the mouse cortex and enhanced learning.
    Holter MC; Hewitt LT; Koebele SV; Judd JM; Xing L; Bimonte-Nelson HA; Conrad CD; Araki T; Neel BG; Snider WD; Newbern JM
    PLoS Genet; 2019 Apr; 15(4):e1008108. PubMed ID: 31017896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAS signaling pathway mutations and hypertrophic cardiomyopathy: getting into and out of the thick of it.
    Gelb BD; Tartaglia M
    J Clin Invest; 2011 Mar; 121(3):844-7. PubMed ID: 21339640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noonan syndrome, PTPN11 mutations, and brain tumors. A clinical report and review of the literature.
    Siegfried A; Cances C; Denuelle M; Loukh N; Tauber M; Cavé H; Delisle MB
    Am J Med Genet A; 2017 Apr; 173(4):1061-1065. PubMed ID: 28328117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced MAPK1 Function Causes a Neurodevelopmental Disorder within the RASopathy Clinical Spectrum.
    Motta M; Pannone L; Pantaleoni F; Bocchinfuso G; Radio FC; Cecchetti S; Ciolfi A; Di Rocco M; Elting MW; Brilstra EH; Boni S; Mazzanti L; Tamburrino F; Walsh L; Payne K; Fernández-Jaén A; Ganapathi M; Chung WK; Grange DK; Dave-Wala A; Reshmi SC; Bartholomew DW; Mouhlas D; Carpentieri G; Bruselles A; Pizzi S; Bellacchio E; Piceci-Sparascio F; Lißewski C; Brinkmann J; Waclaw RR; Waisfisz Q; van Gassen K; Wentzensen IM; Morrow MM; Álvarez S; Martínez-García M; De Luca A; Memo L; Zampino G; Rossi C; Seri M; Gelb BD; Zenker M; Dallapiccola B; Stella L; Prada CE; Martinelli S; Flex E; Tartaglia M
    Am J Hum Genet; 2020 Sep; 107(3):499-513. PubMed ID: 32721402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.